Literature DB >> 2105341

Intracellular glucose oxidation and glycogen synthase activity are reduced in non-insulin-dependent (type II) diabetes independent of impaired glucose uptake.

A W Thorburn1, B Gumbiner, F Bulacan, P Wallace, R R Henry.   

Abstract

To examine whether reduced rates of oxidative (Gox) and non-oxidative (Nox) glucose metabolism in non-insulin-dependent diabetes mellitus (NIDDM) are due to reduced glucose uptake, intrinsic defects in intracellular glucose metabolism or increased fat oxidation (Fox), indirect calorimetry was performed at similar glucose uptake rates in eight nonobese NIDDM and eight comparable nondiabetic subjects. Three glucose clamp studies were performed: one in the nondiabetic and two in the NIDDM subjects. In the nondiabetic subjects, glucose uptake was increased to 7.62 +/- 0.62 mg/kg of fat-free mass (FFM) per min by increasing serum insulin to 309 pmol/liter at a glucose concentration of 5.1 mmol/liter. By raising the concentration of either serum glucose or insulin fourfold in the NIDDM subjects, glucose uptake was matched to nondiabetic subjects (8.62 +/- 0.49 and 8.59 +/- 0.51 mg/kg FFM per min, respectively, P = NS). Skeletal muscle glycogen synthase activity and plasma lactate levels were measured to characterize Nox. When glucose uptake was matched to nondiabetics by hyperglycemia or hyperinsulinemia, Gox was reduced by 26-28% in NIDDM (P less than 0.025) whereas Fox was similar. Nox was greater in NIDDM (P less than 0.01) and was accompanied by increases in circulating lactate levels. Glycogen synthase activity was reduced by 41% (P less than 0.025) when glucose uptake was matched by hyperglycemia. Glycogen synthase activity was normalized in NIDDM, however, when glucose uptake was matched by hyperinsulinemia. Therefore, a defect in Gox exists in nonobese NIDDM subjects which cannot be overcome by increasing glucose uptake or insulin. Since both glucose uptake and Fox were similar in the two subject groups these factors were not responsible for reduced Gox. Increased Nox in NIDDM is primarily into lactate. Reduced glycogen synthase activity in NIDDM is independent of glucose uptake but can be overcome by increasing the insulin concentration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105341      PMCID: PMC296454          DOI: 10.1172/JCI114468

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  48 in total

1.  Overnutrition induced decrease in insulin action for glucose storage: in vivo and in vitro in man.

Authors:  D M Mott; S Lillioja; C Bogardus
Journal:  Metabolism       Date:  1986-02       Impact factor: 8.694

2.  Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.

Authors:  K S Wright; H Beck-Nielsen; O G Kolterman; L J Mandarino
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

3.  Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man.

Authors:  R A DeFronzo; E Ferrannini; R Hendler; P Felig; J Wahren
Journal:  Diabetes       Date:  1983-01       Impact factor: 9.461

4.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.

Authors:  R A DeFronzo; R Gunnarsson; O Björkman; M Olsson; J Wahren
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.

Authors:  M R Taskinen; C Bogardus; A Kennedy; B V Howard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  Correlation between muscle glycogen synthase activity and in vivo insulin action in man.

Authors:  C Bogardus; S Lillioja; K Stone; D Mott
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

7.  Study on lipid metabolism in obesity diabetes.

Authors:  A Golay; J P Felber; H U Meyer; B Curchod; E Maeder; E Jéquier
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

8.  Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance.

Authors:  S Lillioja; D M Mott; J K Zawadzki; A A Young; W G Abbott; C Bogardus
Journal:  J Clin Endocrinol Metab       Date:  1986-05       Impact factor: 5.958

9.  Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients. Effects of improving glycemic control.

Authors:  G Boden; T K Ray; R H Smith; O E Owen
Journal:  Diabetes       Date:  1983-11       Impact factor: 9.461

10.  Relationship between insulin-mediated glucose disposal and lipid metabolism in man.

Authors:  S Lillioja; C Bogardus; D M Mott; A L Kennedy; W C Knowler; B V Howard
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

View more
  45 in total

Review 1.  Alterations of glucose metabolism in type 2 diabetes mellitus. An overview.

Authors:  Riccardo C Bonadonna
Journal:  Rev Endocr Metab Disord       Date:  2004-05       Impact factor: 6.514

2.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 3.  Metabolic and molecular basis of insulin resistance.

Authors:  Mandeep Bajaj; Ralph A Defronzo
Journal:  J Nucl Cardiol       Date:  2003 May-Jun       Impact factor: 5.952

Review 4.  Insulin resistance in non-insulin-dependent diabetes mellitus. A review.

Authors:  A A Alzaid
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

5.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

6.  Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance.

Authors:  Theodore P Ciaraldi; Vanita Aroda; Sunder Mudaliar; R Jeffrey Chang; Robert R Henry
Journal:  J Clin Endocrinol Metab       Date:  2008-10-14       Impact factor: 5.958

7.  Hyperglycaemia compensates for the defects in insulin-mediated glucose metabolism and in the activation of glycogen synthase in the skeletal muscle of patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  A Vaag; P Damsbo; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

Review 8.  Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J P Felber; E Haesler; E Jéquier
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

9.  Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial.

Authors:  Vanita R Aroda; Theodore P Ciaraldi; Paivi Burke; Sunder Mudaliar; Paul Clopton; Susan Phillips; R Jeffrey Chang; Robert R Henry
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

10.  Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate.

Authors:  Jose E Galgani; Leonie K Heilbronn; Koichiro Azuma; David E Kelley; Jeanine B Albu; Xavier Pi-Sunyer; Steven R Smith; Eric Ravussin
Journal:  Diabetes       Date:  2008-02-19       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.